Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-10,114
Closed -$36K – 4837
2026
Q1
$36K Sell
10,114
-22,352
-69% -$77.3K ﹤0.01% 3503
2025
Q4
$110K Buy
+32,466
New +$158K ﹤0.01% 2771
2025
Q2
– Sell
-10,740
Closed -$58K – 3160
2025
Q1
$58K Sell
10,740
-7,972
-43% -$45.2K ﹤0.01% 2227
2024
Q4
$92K Buy
+18,712
New +$98.1K ﹤0.01% 2047
2024
Q2
– Sell
-73,457
Closed -$755K – 2695
2024
Q1
$755K Buy
+73,457
New +$543K ﹤0.01% 1032
2021
Q3
– Sell
-23,813
Closed -$280K – 3540
2021
Q2
$280K Buy
+23,813
New +$274K ﹤0.01% 2186

Other funds holding LFMD

HRT Financial's LFMD Position: Q2 2026 in Review

HRT Financial sold out of LifeMD (LFMD) in Q2 2026, closing a stake of 10,114 shares — an estimated $36K sold.

HRT Financial first reported a position in LFMD in Q2 2021 and held it in 6 quarters. The position peaked at $755K in Q1 2024. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • HRT Financial reported no remaining LifeMD position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 10,114 LifeMD shares in Q2 2026, an estimated $36K.
  • HRT Financial first reported a position in LifeMD in Q2 2021 and held it in 6 quarters.
  • HRT Financial's LifeMD position peaked at $755K in Q1 2024.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.